Impact Factor
3.31
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.52
348 total citations
h5-index
34
h5 depth signal
Cited share
71.8%
112 of 156
Total citations
348
Citation footprint
Metric signal
2.50
External metric anchor
Self-citation
7.8%
27 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
499
United Kingdom
211
Canada
151
Netherlands
117
Australia
76
Citing Fields of Research
Medical Ethics
427
Patient Care
212
Statistical Methods
169
Healthcare Policy
126
Health Education & Remote Healthcare
112
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,763
Articles tracked across the journal lifetime
Indexed publication set
156
112 cited publications
Last 12 months
98
8.2 publications/month
Open access share
45.9%
45 OA publications in the last year
Leading citing country
United States
499 citing publications
Leading citing field
Medical Ethics
427 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1981-
v1n1, 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Medical Ethics
Patient Care
Statistical Methods
Oncology
Healthcare Policy
Economics
Issuing & Sponsoring Bodies
Contributor
Society for Medical Decision Making (U.S.)
Broad Categories
Health Services Research
Medical Informatics
Medical Ethics
Statistical Methods
Patient Care
Psychiatry & Psychology
Genetics & Genomics
Palliative Care
MeSH Descriptors
Decision Making
Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/0272989x261493550
Open DOI
Association between Trust and Patient-Reported Outcomes and Experience in Prostate Cancer Patients
Purpose: To evaluate the association between patient–physician trust, treatment choice, patient-reported outcomes, and patient-reported experiences among patients with localized prostate cancer. Materials and Methods: We conducted a seco...
02
DOI 10.1177/0272989x261489534
Open DOI
Why QALY Estimates Differ in Cervical Cancer Screening: An In-Depth Exploration Using CISNET Comparative Modeling
Background: Quality-adjusted life-years (QALYs) are commonly used as a measure for evaluating the value of cancer screening. However, it is often unclear what drives model-based QALY estimates. We examine factors influencing QALY estimat...
03
DOI 10.1177/0272989x261487434
Open DOI
A Conceptual Roadmap toward Informed Prenatal Genetic Screening and Diagnostic Testing: A Qualitative Study
Introduction: Prenatal genetic screening and diagnostic tests (PS&D) are a core component of the delivery of high-quality, evidence-based prenatal care. There is a paucity of evidence on how to structure decision-making processes that ar...
04
DOI 10.1177/0272989x261485229
Open DOI
Distributional Cost-Effectiveness Analysis Using Microsimulation in R: A Tutorial
Introduction/Purpose: Distributional cost-effectiveness analysis (DCEA) extends traditional cost-effectiveness analysis by explicitly incorporating concerns about health inequality. Decision models are central to health economic evaluati...
05
DOI 10.1177/0272989x261485304
Open DOI
Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Leveraging Electronic Health Record Data
Purpose: Many patients with advanced cancers undergo multiple lines of treatment. Optimal therapy sequence (ie, what therapies are given and in what order) is often unknown. We developed methods for estimating quality-adjusted outcomes a...
06
DOI 10.1177/0272989x261487110
Open DOI
Social Diffusion and Peer Influence on Guideline-Adherent Tonsillectomy Prescribing in German Otolaryngologists: A Cross-Sectional Study
Background: Despite clear recommendations from evidence-based guidelines to restrict tonsillectomies for adult patients with infrequent tonsillitis, adoption among German otolaryngologists remains limited. Social influences, including op...
07
DOI 10.1177/0272989x261484970
Open DOI
Women’s Attitudes toward the 2024 US Preventive Services Task Force Mammography Screening Guideline
Background: From 2009 to 2024, the US Preventive Services Task Force (USPSTF) recommended that women aged 40 to 49 y make an informed choice about when to begin having mammograms. In 2024, the USPSTF changed its guidelines, recommending ...
08
DOI 10.1177/0272989x261484927
Open DOI
AI Quality and Clinical Roles Impact Decision Quality in AI-Augmented Medical Decisions More than AI Explanations
Background: Explainable AI has garnered significant attention in recent years, particularly in high-risk domains such as health care. Despite the enthusiasm, empirical evidence on the impact of AI explanations remains mixed. This study e...
09
DOI 10.1177/0272989x261473873
Open DOI
Giddy up! Can We Reduce Dropouts in a Discrete-Choice Experiment by Including an Encouraging Message? A Randomised Trial
Background: Discrete-choice experiments (DCEs) are valuable in establishing health preferences. However, their repetitive nature may cause dropouts. Aim: Does an encouraging ‘giddy-up’ message improve completion rates, data quality and r...
10
DOI 10.1177/0272989x261485280
Open DOI
Beyond Agency Acceptance: Toward a Methodological Standard for Survival Extrapolation in Oncology HTA
Bibliographical & Catalog Notes
Title from cover.
Place of publication varies.
Also issued online.
19950523 Not printed on acid-free paper